The core problem: language models are persuasive even when they are guessing Large language models excel at producing coherent text...
Read moreA single download can transform care delivery. When the U.S. Food and Drug Administration cleared Pear Therapeutics’ Somryst application—an app...
Read moreA subtle vibration can steady a hand yet unvoiced hazards accompany this new pulse. On July 2, the U.S. Food...
Read moreA whirr of mechanical arms and the soft glow of a console screen now guide surgeons’ hands toward incisions measured...
Read moreA subtle upheaval unfolds in psychological services as algorithmic therapists converse with patients at odd hours and headsets transport trauma...
Read moreThe Disappearance of the Waiting Room Until recently, diagnosis in medicine occurred primarily in discrete moments—a scheduled visit, a test...
Read moreA Solution 80 Years Overdue Since the first wartime plasma transfusions in the 1940s, blood has remained a biologically necessary,...
Read moreOn a Tuesday morning in Nottingham, surgeons hovered over a glioblastoma no bigger than a walnut while a pocket-sized sequencer...
Read moreThe surgical theater has always been humanity’s most intimate battleground against illness—a sacred arena where human skill meets nature’s uncertainty....
Read moreIn the packed halls of ASCO 2025, amid a sea of abstract posters and hushed clinical optimism, one phrase echoed...
Read moreIt began quietly, almost unnoticed—until the digital landscape ignited. Researchers at Johns Hopkins University unveiled an artificial intelligence-driven blood test...
Read moreA clot moves in silence—until it kills. That brutal, biological truth has haunted emergency rooms for decades. Strokes, heart attacks,...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy